First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis

Overview of attention for article published in Frontiers in oncology, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 17 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,421 followers.

New article: First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis https://t.co/435rqKbEy6 #lungcancer #oncology https://t.co/uJUO7AtbCs

16 Jul 2021

Reply Repost Favourite

New research: First-Line Chemo-Immunotherapy for Extensive-Stage Small-Cell Lung Cancer: A United States-Based Cost-Effectiveness Analysis: Objective This study aimed to assess the cost-effectiveness of two recently approved first-line… https://t.co/StosLl

29 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.